ArticleThe Lancet regional health. Europe2025

Effectiveness of nirsevimab against hospitalisation for RSV-bronchiolitis during high RSV-B circulation in the second year of nationwide implementation in France: a test-negative case-control study.

Apolline Furgier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.